Secondary Logo

Journal Logo

September-October 2004 - Volume 27 - Issue 5
pp: 329-418


Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy

Ribas, Antoni; Glaspy, John A.; Lee, Yohan; More

Journal of Immunotherapy. 27(5):354-367, September-October 2004.

Assessment of the Toxicities of Systemic Low-Dose Interleukin-2 Administered in Conjunction with a Melanoma Peptide Vaccine

Woodson, Elizabeth M. H.; Chianese-Bullock, Kimberly A.; Wiernasz, Catherine J.; More

Journal of Immunotherapy. 27(5):380-388, September-October 2004.

Quantitative Molecular Evaluation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia: Efficacy of In Vivo Purging by Alemtuzumab (Campath-1H)

Galimberti, Sara; Cervetti, Giulia; Cecconi, Nadia; More

Journal of Immunotherapy. 27(5):389-393, September-October 2004.

A Randomized Controlled Study of Immunochemotherapy with OK-432 after Curative Surgery for Gastric Cancer

Sato, Yuji; Kondo, Masao; Kohashi, Shigechika; More

Journal of Immunotherapy. 27(5):394-397, September-October 2004.